Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3893 | 838 | 41.4 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
3893 | 2 | PRL 3//ATF3//ATF5 | 838 |
21300 | 1 | ATF3//ACTIVATING TRANSCRIPTION FACTOR 3//ACTIVATING TRANSCRIPTION FACTOR 3 ATF3 | 425 |
26440 | 1 | PRL 3//PHOSPHATASE OF REGENERATING LIVER 3//PRL 1 | 255 |
35063 | 1 | ATF5//ACTIVATING TRANSCRIPTION FACTOR 5//BATF2 | 103 |
37546 | 1 | KIAA0101//NS5ATP9//OEATC 1 | 55 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRL 3 | authKW | 1999279 | 8% | 84% | 65 |
2 | ATF3 | authKW | 1213049 | 8% | 48% | 69 |
3 | ATF5 | authKW | 724440 | 3% | 76% | 26 |
4 | ACTIVATING TRANSCRIPTION FACTOR 3 | authKW | 619965 | 4% | 52% | 33 |
5 | ACTIVATING TRANSCRIPTION FACTOR 3 ATF3 | authKW | 457829 | 2% | 74% | 17 |
6 | JDP2 | authKW | 446349 | 2% | 88% | 14 |
7 | PHOSPHATASE OF REGENERATING LIVER 3 | authKW | 403607 | 1% | 92% | 12 |
8 | PRL 1 | authKW | 403607 | 1% | 92% | 12 |
9 | KIAA0101 | authKW | 327932 | 1% | 100% | 9 |
10 | PTP4A3 | authKW | 314914 | 1% | 79% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2298 | 28% | 0% | 236 |
2 | Biochemistry & Molecular Biology | 1634 | 38% | 0% | 321 |
3 | Cell Biology | 1340 | 22% | 0% | 182 |
4 | Biophysics | 185 | 6% | 0% | 54 |
5 | Genetics & Heredity | 155 | 7% | 0% | 59 |
6 | Medicine, Research & Experimental | 140 | 6% | 0% | 50 |
7 | Pathology | 80 | 3% | 0% | 29 |
8 | Nutrition & Dietetics | 27 | 2% | 0% | 18 |
9 | Developmental Biology | 18 | 1% | 0% | 11 |
10 | Biotechnology & Applied Microbiology | 11 | 3% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PANCREAT GASTROENTEROL SURG | 116597 | 0% | 80% | 4 |
2 | EQUIPE GENES NUTRIMENTS | 72874 | 0% | 100% | 2 |
3 | MODEL ANIM GENET | 72874 | 0% | 100% | 2 |
4 | UR NUTR CELLULAIRE MOL 238 | 72874 | 0% | 100% | 2 |
5 | ENVIRONM MOL PHYSIOL | 71406 | 1% | 28% | 7 |
6 | GENET SHANDS CANC | 65584 | 0% | 60% | 3 |
7 | GASTROENTEROPANCREAT SURG | 64772 | 0% | 44% | 4 |
8 | GENOME STRUCT REGULAT | 64772 | 0% | 44% | 4 |
9 | UNITE NUTR CELLULAIRE MOL | 56926 | 1% | 31% | 5 |
10 | CHEM GENOM BIOL | 48581 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1191 | 9% | 0% | 73 |
2 | ONCOGENE | 1126 | 3% | 0% | 24 |
3 | YIDDISH | 742 | 0% | 2% | 1 |
4 | ONCOTARGET | 644 | 2% | 0% | 15 |
5 | MOLECULAR AND CELLULAR BIOLOGY | 560 | 2% | 0% | 19 |
6 | MOLECULAR CANCER THERAPEUTICS | 559 | 1% | 0% | 8 |
7 | MOLECULAR CANCER | 506 | 1% | 0% | 5 |
8 | CANCER RESEARCH | 500 | 3% | 0% | 24 |
9 | MOLECULAR CANCER RESEARCH | 479 | 1% | 0% | 5 |
10 | PATHOLOGY & ONCOLOGY RESEARCH | 450 | 0% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRL 3 | 1999279 | 8% | 84% | 65 | Search PRL+3 | Search PRL+3 |
2 | ATF3 | 1213049 | 8% | 48% | 69 | Search ATF3 | Search ATF3 |
3 | ATF5 | 724440 | 3% | 76% | 26 | Search ATF5 | Search ATF5 |
4 | ACTIVATING TRANSCRIPTION FACTOR 3 | 619965 | 4% | 52% | 33 | Search ACTIVATING+TRANSCRIPTION+FACTOR+3 | Search ACTIVATING+TRANSCRIPTION+FACTOR+3 |
5 | ACTIVATING TRANSCRIPTION FACTOR 3 ATF3 | 457829 | 2% | 74% | 17 | Search ACTIVATING+TRANSCRIPTION+FACTOR+3+ATF3 | Search ACTIVATING+TRANSCRIPTION+FACTOR+3+ATF3 |
6 | JDP2 | 446349 | 2% | 88% | 14 | Search JDP2 | Search JDP2 |
7 | PHOSPHATASE OF REGENERATING LIVER 3 | 403607 | 1% | 92% | 12 | Search PHOSPHATASE+OF+REGENERATING+LIVER+3 | Search PHOSPHATASE+OF+REGENERATING+LIVER+3 |
8 | PRL 1 | 403607 | 1% | 92% | 12 | Search PRL+1 | Search PRL+1 |
9 | KIAA0101 | 327932 | 1% | 100% | 9 | Search KIAA0101 | Search KIAA0101 |
10 | PTP4A3 | 314914 | 1% | 79% | 11 | Search PTP4A3 | Search PTP4A3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CAMPBELL, AM , ZHANG, ZY , (2014) PHOSPHATASE OF REGENERATING LIVER: A NOVEL TARGET FOR CANCER THERAPY.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 18. ISSUE 5. P. 555 -569 | 77 | 91% | 5 |
2 | RIOS, P , LI, X , KOHN, M , (2013) MOLECULAR MECHANISMS OF THE PRL PHOSPHATASES.FEBS JOURNAL. VOL. 280. ISSUE 2. P. 505-524 | 77 | 64% | 25 |
3 | PAGARIGAN, KT , BUNN, BW , GOODCHILD, J , RAHE, TK , WEIS, JF , SAUCEDO, LJ , (2013) DROSOPHILA PRL-1 IS A GROWTH INHIBITOR THAT COUNTERACTS THE FUNCTION OF THE SRC ONCOGENE.PLOS ONE. VOL. 8. ISSUE 4. P. - | 59 | 87% | 2 |
4 | GUZINSKA-USTYMOWICZ, K , PRYCZYNICZ, A , (2011) PRL-3, AN EMERGING MARKER OF CARCINOGENESIS, IS STRONGLY ASSOCIATED WITH POOR PROGNOSIS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 11. ISSUE 1. P. 99 -108 | 54 | 90% | 17 |
5 | AL-AIDAROOS, AQO , ZENG, Q , (2010) PRL-3 PHOSPHATASE AND CANCER METASTASIS.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 111. ISSUE 5. P. 1087 -1098 | 62 | 70% | 48 |
6 | BAI, YP , YU, ZH , LIU, SJ , ZHANG, LJ , ZHANG, RY , ZENG, LF , ZHANG, S , ZHANG, ZY , (2016) NOVEL ANTICANCER AGENTS BASED ON TARGETING THE TRIMER INTERFACE OF THE PRL PHOSPHATASE.CANCER RESEARCH. VOL. 76. ISSUE 16. P. 4805 -4815 | 39 | 83% | 1 |
7 | DUMAUAL, CM , SANDUSKY, GE , SOO, HW , WERNER, SR , CROWELL, PL , RANDALL, SK , (2012) TISSUE-SPECIFIC ALTERATIONS OF PRL-1 AND PRL-2 EXPRESSION IN CANCER.AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH. VOL. 4. ISSUE 1. P. 83-101 | 47 | 78% | 8 |
8 | RUBIO, T , KOHN, M , (2016) REGULATORY MECHANISMS OF PHOSPHATASE OF REGENERATING LIVER (PRL)-3.BIOCHEMICAL SOCIETY TRANSACTIONS. VOL. 44. ISSUE . P. 1305 -1312 | 40 | 77% | 0 |
9 | SHARLOW, ER , WIPF, P , MCQUEENEY, KE , BAKAN, A , LAZO, JS , (2014) INVESTIGATIONAL INHIBITORS OF PTP4A3 PHOSPHATASE AS ANTINEOPLASTIC AGENTS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 23. ISSUE 5. P. 661 -673 | 46 | 68% | 3 |
10 | BESSETTE, DC , QIU, DX , PALLEN, CJ , (2008) PRL PTPS: MEDIATORS AND MARKERS OF CANCER PROGRESSION.CANCER AND METASTASIS REVIEWS. VOL. 27. ISSUE 2. P. 231 -252 | 54 | 52% | 95 |
Classes with closest relation at Level 2 |